SCHEMBL11818248

SCHEMBL11818248

Cc1cccc(CSc2ccc(S(=O)(=O)C(F)(F)F)cc2C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.43
▸ CA4 P22748 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.41
▸ TAS2R14 Q9NYV8 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ PTGDR2 Q9Y5Y4 1/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ PTPRG P23470 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ HPGD P15428 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ PSMD14 O00487 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11818479 0.91 CA2 (0.46) CA2CA4ALDH1A1RXFP1KMT2A
SCHEMBL11820018 0.88 CA2 (0.53) CA2CA4ALDH1A1RXFP1KMT2A
SCHEMBL11821491 0.87 MEN1 (0.45) CA2CA4ALDH1A1KMT2AMEN1
SCHEMBL11816258 0.86 CYP1A2 (0.46) CA2CA4ALDH1A1TAS2R14PTGDR2
SCHEMBL11825522 0.84 ALDH1A1 (0.46) CA2CA4ALDH1A1KMT2AMEN1
SCHEMBL11817200 0.83 ALDH1A1 (0.53) CA2CA4ALDH1A1TAS2R14KMT2A
SCHEMBL10741558 0.81 FKBP1A (0.47) ALDH1A1PTPRGL3MBTL1HPGDLMNA
SCHEMBL11817917 0.81 PTPRG (0.47) CA2CA4KMT2AMEN1PTPRG
SCHEMBL11814899 0.81 PPARD (0.43) CA2CA4PTPRGL3MBTL1ACLY
SCHEMBL11817140 0.81 CA2 (0.42) CA2CA4ALDH1A1RXFP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback